Skip to main content
search
Category

Home

MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model

 October 3, 2023
October 3, 2023

Participation terms in the Combined General Meeting

 August 21, 2023
August 21, 2023

MedinCell has received the last tranche of €10m from the European Investment Bank (EIB) loan

 July 31, 2023
July 31, 2023

MedinCell announces the availability of its 2022-23 Universal Registration Document including the Annual Financial Report

 July 31, 2023
July 31, 2023

MedinCell announces its full year financial results April 2022 – March 2023

 June 26, 2023
June 26, 2023

MedinCell will publish its annual results (April 2022-March 2023) on June 26, 2023

 June 5, 2023
June 5, 2023

Phase 1 data of mdc-TJK investigational long-acting injectable of olanzapine for schizophrenia patients, exhibited favorable characteristics of an extended-release profile

 May 22, 2023
May 22, 2023

Better medicine for all

© 2024 Medincell. All rights reserved.

Website by ScreenUp